Solid Biosciences

Recent news

• Truist Financial Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $20
  Market Newswire · 2026/8/21
• Piper Sandler Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2026/9/30
• Rating change
  Citi Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/9/11
• Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $26
  Market Newswire · 2026/9/16
• Rating change
  William Blair Maintains Solid Biosciences(SLDB.US) With Buy Rating
  Market Newswire · 2026/8/7
• Rating change
  H.C. Wainwright Remains a Buy on Solid Biosciences (SLDB)
  TipRanks · 2026/5/15
• Leerink Partners Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $20
  Market Newswire · 2026/9/16
• Rating change
  Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/5/13
• Rating change
  J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $11
  Market Newswire · 2026/8/11
• Rating change
  J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Cuts Target Price to $11
  Market Newswire · 2026/5/23
• Rating change
  H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $20
  Market Newswire · 2026/5/15
• Rating change
  Cantor Fitzgerald Maintains Solid Biosciences(SLDB.US) With Buy Rating, Raises Target Price to $26
  Market Newswire · 2026/8/27
• Rating change
  H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Raises Target Price to $25
  Market Newswire · 2026/6/3
• Rating change
  RBC Capital Initiates Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $18
  Market Newswire · 2026/9/16
• Company notice
  Solid Biosciences: Solid Biosciences Inc. - Reverse Split Option Symbol: SLDB New Symbol: SLDB1
  OCC · 2022/10/27
• Rating change
  J.P. Morgan Reaffirms Their Buy Rating on Solid Biosciences (SLDB)
  TipRanks · 2026/5/23
• Rating change
  Chardan Capital Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15
  Market Newswire · 2026/5/14
• H.C. Wainwright Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $25
  Market Newswire · 2026/9/14
• Rating change
  Needham Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $19
  Market Newswire · 2026/8/7
• Rating change
  Wedbush Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/5/18

Headlines are aggregated automatically and are not independently verified or edited by our team.